PAVmed (PAVM) vs SkyAI (SKYA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SkyAI (SKYA) has outperformed PAVmed (PAVM) over the past year, losing 23.0% versus a loss of 88.8%. PAVmed is the larger company by market cap ($9.1 million vs $7.8 million), about 1.2 times the size. PAVmed converts more of its revenue into profit, with a net margin of 564.8% versus -138400.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PAVM | SKYA |
|---|---|---|
| Share price | $1.14 | $2.18 |
| Market cap | $9.08M | $7.82M |
| 1-day change | -5.42% | -45.50% |
| YTD return | -82.88% | +7.39% |
| 1-year return | -88.77% | -22.97% |
| 5-year return | -99.93% | — |
| P/E ratio (TTM) | — | 2.83 |
| EPS (TTM) | $-7.33 | $0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $71.00K | $204.12K |
| Revenue growth (YoY) | -97.63% | — |
| Net income (latest FY) | $401.00K | $-282.50M |
| Gross margin | -207.04% | -202.49% |
| Operating margin | -30712.68% | -132145.49% |
| Net margin | 564.79% | -138400.02% |
| 52-week high | $28.44 | $4.39 |
| 52-week low | $1.10 | $0.91 |
| Distance from 52-week high | -96.01% | -50.34% |
| Analyst consensus | none | — |
| Avg. price target upside | +3115.86% | — |
| Average volume | 23.70K | 1.74M |
| Shares outstanding | 8.00M | 3.59M |
| Employees | 41 | 30 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SKYA has outperformed PAVM by 65.8 percentage points over the past year.
- PAVmed is more profitable, keeping 564.8 cents of every revenue dollar as net income versus -138400.0 cents for SkyAI.
About PAVmed
PAVM stock →PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
Health Care · Medical/Dental Instruments · 41 employees
About SkyAI
SKYA stock →SkyAI, Inc., a financial technology company with a Solana digital asset treasury that is building an agentic finance platform. It combines stablecoin rails with AI to deliver financial access, education, and actionable intelligence to the underbanked users in Asia, Latin America, and Africa.
Health Care · Medical/Dental Instruments · 30 employees
PAVM vs SKYA FAQ
Which is bigger, PAVmed or SkyAI?
PAVmed (PAVM) is larger, with a market capitalization of $9.08M compared with $7.82M for SkyAI (SKYA).
Which stock has performed better over the past year, PAVM or SKYA?
SKYA returned -22.97% over the past 12 months, compared with -88.77% for PAVM (price return, excluding dividends). Past performance does not predict future results.
Are PAVmed and SkyAI in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.